Definitive Contract 75N94021C00007

Award Date 9/30/21
Potential Completion Date 9/29/24
Potential Value $2.5M
Ultimate Awardee
Not listed
Set-Aside Type
8(a) Sole Source
Federal Contract Vehicle
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded a $227,011.68 delivery order contract to Inode Ink Corporation Khai Huynh Division. This order was issued against the Chief Information Officer - Solutions and Partners 3 Small Business Government-Wide Acquisition Contract (CIO-SP3 SB GWAC) for the purpose of providing Infrastructure System...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1,099,688.48 Delivery Order contract to Cognitive Medical Systems, Inc., a Service-Disabled Veteran-Owned Small Business. The contract is to provide support services for the development of an electronic care plan for persons with multiple chronic conditions. The contract is a Firm Fixed Price agreement and is a set-aside for small...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services, awarded a $175,089.53 firm-fixed price delivery order to Revolutionary Solutions LLC, a woman-owned small business. The order was placed under Revolutionary Solutions' existing Multiple Award Schedule (MAS) contract with the General Services Administration (GSA) and provides administrative support services to...
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $25,000 purchase order contract to Build Clinical, LLC of New York, New York. Under the terms of the contract, Build Clinical will provide recruitment services to NIDDK for the period of September 18, 2023 through September 17, 2024. As the lead institute for diabetes, digestive, and kidney research within the Department of Health and Human Services, NIDDK seeks to accelerate...
This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency, to The Emmes Company LLC, a for-profit limited liability company. The contract is for a Data Coordinating Center to support the Diabetes Risk Across Women's Lifespan Study, with a ceiling value of $324,444.77 and a period of performance ending on January 29, 2017. The contract is a Delivery Order under a Cost Plus Fixed Fee pricing type and was not set aside for any...
EMI Advisors LLC was awarded a $1.2 million purchase order by the Department of Health and Human Services' National Institutes of Health Office of Logistics and Acquisition Operations to deliver services under the ONC PHIT Workforce Development Program. The firm fixed price contract runs from September 2021 through September 2024 and has an 8(a) sole source designation. EMI Advisors will provide workforce training and development services to support the Office of the National Coordinator for...
The Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed-price purchase order to Eggers Paul, an Other Not For Profit Organization, to provide epidemiology statistical consulting services. The award, valued at $125,000.00, has a period of performance from May 1, 2020 to April 30, 2025 and was made without full and open competition under the procedures of Federal Acquisition...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases to The Emmes Company LLC, a for-profit limited liability company. The contract, with a potential value of $5,157,873.24, is for a Transplant Registry and was awarded on September 29, 2006 with a completion date of July 31, 2011. It is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and there was no...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $80,095.43 firm fixed price delivery order against the General Services Administration (GSA) Multiple Award Schedule to Shimadzu Scientific Instruments, Inc. for a preparatory high performance liquid chromatography (HPLC) system. Performance will take place in Columbia, Maryland from June 30, 2023...
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $55,000 firm fixed price delivery order against Technuf, LLC's Multiple Award Schedule contract. Under this contract, Technuf, LLC will provide QlikSense software access to NIDDK from August 2023 through August 2024. As the lead institute for diabetes, digestive, and kidney research under the Department of Health and Human Services, NIDDK aims to translate and use innovative data...

EMI Advisors LLC has been awarded a definitive contract valued at approximately $2.5 million by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is a part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract calls for EMI Advisors LLC to develop an electronic care plan for persons with multiple chronic conditions, known as the E-CARE program. Performance will take place in Bethesda, Maryland over a three year period concluding in September 2024. The contract has a firm fixed price and has been set aside for the 8(a) Business Development Program. No major subcontractors were identified. NIDDK conducts research to support care and treatments for diabetes and other endocrine and metabolic diseases, digestive diseases, kidney and urologic diseases, and hematologic diseases.

Generated 12/25/23, 3:37 AM